Account Support Representative (ASR) at BillionToOne

Philadelphia, Pennsylvania, United States

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Biotechnology, DiagnosticsIndustries

Requirements

Bachelor’s degree required, preferably in a science, healthcare, or business-related field
1+ years of experience in a sales support or customer-facing role; healthcare or medical sales background strongly preferred
Excellent communication and organizational skills
Self-motivated, team-oriented, and adaptable to shifting priorities
Proficiency in Microsoft Office (Excel, PowerPoint), Google Suite, and CRM systems like Salesforce
Willingness to travel regionally to support field coverage, up to 50% travel required

Responsibilities

Provide regional assistance by supporting the daily needs of the sales team across the assigned territory
Maintain and strengthen relationships with existing customers through proactive account support
Assist with onboarding and training new customers, addressing inquiries, and resolving issues to ensure satisfaction
Act as a liaison between customers, sales representatives, and internal departments to ensure timely follow-up and issue resolution
Provide coverage for open territories, including in-person or virtual customer meetings as needed
Coordinate sample logistics, marketing materials, and other operational tasks as needed
Collaborate closely with internal departments such as marketing, sales operations, and customer support to ensure seamless service delivery

Skills

Sales Support

Customer Service

Account Management

Client Relationships

Onboarding

Customer Training

Issue Resolution

Field Sales

BillionToOne

Molecular diagnostics for prenatal and oncology testing

About BillionToOne

BillionToOne specializes in molecular diagnostics within the healthcare sector, focusing on prenatal screening and oncology testing. Their proprietary QCT technology allows for the detection and quantification of diseases at a single base-pair resolution, enabling the identification of minute variations in DNA. The company offers two main products: Northstar Select™, which helps determine the best initial therapy for patients, and Northstar Response™, which tracks the effectiveness of that therapy. Unlike many competitors, BillionToOne emphasizes accuracy, efficiency, and accessibility in molecular testing, providing diagnostic services directly to healthcare providers. Their goal is to positively impact healthcare by making molecular testing more reliable and available to everyone.

Menlo Park, CaliforniaHeadquarters

2016Year Founded

$380.2MTotal Funding

SERIES_DCompany Stage

Biotechnology, HealthcareIndustries

201-500Employees

Benefits

Competitive pay

Retirement savings package

Parental leave

Free snacks & lunches

Medical, dental, & vision premiums

On campus perks

Free-on-site EV charging

Risks

Emerging biotech startups could threaten BillionToOne's market share.

Rapid technological advancements may render their current technology obsolete.

Expansion into new facilities may face operational challenges or delays.

Differentiation

BillionToOne's QCT technology detects DNA variations at single base-pair resolution.

Their UNITY Fetal Antigen NIPT is the first US cfDNA test for fetal antigen genotyping.

They replace invasive amniocentesis with a safe, affordable blood test for prenatal screening.

Upsides

BillionToOne achieved a billion-dollar valuation with a $130 million funding round.

Their new Austin facility will create 1,000 jobs, boosting production and local economy.

Recognition as Diagnostics Company of the Year highlights their industry leadership.

Land your dream remote job 3x faster with AI

Try Jobo Free